New Key Statistics Module, Z-Score and F-Score
OTCPK:PCLOF Key Ratios
| Market Cap $ M | 19.25 |
| Enterprise Value $ M | 31.47 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 9.12 |
| Price/Sales | 8.61 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -0.06 |
| Beneish M-Score | 7.03 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.16 |
| EV-to-EBITDA | -4.81 |
| PEG | -- |
| Shares Outstanding M | 170.38 |
| Net Margin (%) | -456.07 |
| Operating Margin % | -357.45 |
| Pre-tax Margin (%) | -456.07 |
| Quick Ratio | 0.17 |
| Current Ratio | 0.45 |
| ROA % (ttm) | -49.32 |
| ROE % (ttm) | -243.88 |
| ROIC % (ttm) | -43.35 |
| Dividend Yield % | -- |
| Altman Z-Score | -10.82 |
PCLOF Number of Guru Trades
PCLOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:PCLOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PCLOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
PharmaCielo Ltd Insider Transactions
No Available Data
News about OTCPK:PCLOF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers